首页 › 基金 › BFSG, LLC › SOLV

BFSG, LLC 对 SOLV 的持仓历史

SOLVENTUM CORP · 医疗保健

BFSG, LLC 在 Q3 2026 的 13F 申报中披露持有 SOLV(SOLVENTUM CORP)85,434 股,市值约 US$7.5M,约占其申报组合的 0.69%,在其申报持仓中市值排名第 38 位。 BFSG, LLC 最近 2 个申报季度中有 2 个季度披露了 SOLV 持仓,最早可追溯至 Q2 2026。

最新持仓 (Q3 2026)85.43K 股
申报持仓市值$7.53M
组合权重0.69%
首次申报Q2 2026
最近变动减持
更新于2026-11-13

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

BFSG, LLC 对 SOLV 的持仓演变

BFSG, LLC 于 Q2 2026 首次披露 SOLV 持仓:87,227 股(约 US$6.7M)。 该持仓在 Q3 2026 达到峰值 85,434 股,市值约 US$7.5M。 在 2 次申报中,BFSG, LLC 0 次增持、1 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 85,434 股、市值约 US$7.5M,环比减持 -1,793 股。。

逐季持仓明细

季度股数金额变化
Q2 2026 87.23K $6.73M 新进
Q3 2026 85.43K $7.53M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 SOLV 与 13F 数据

SOLV(SOLVENTUM CORP)属于医疗保健行业。我们追踪的基金中还有 41 只申报持有 SOLV,申报仓位最大的包括:Independent Franchise Partners LLP (US$1.38B), TRIAN FUND MANAGEMENT, L.P. (US$635.5M), DAVIS SELECTED ADVISERS (US$565.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 SOLV 的基金

查看 SOLV 的全部基金持有人 →

常见问题

How long has BFSG, LLC held SOLV?

BFSG, LLC has disclosed SOLV holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is BFSG, LLC's current position in SOLV?

As of Q3 2026, BFSG, LLC holds 85.43K shares of SOLV (SOLVENTUM CORP), valued at $7.53M, representing 0.69% of its reported portfolio and ranking #38.

Has BFSG, LLC been buying or selling SOLV?

In the latest 13F filing (Q3 2026), BFSG, LLC reduced its position in SOLV. The position peaked in Q3 2026 at 85.43K shares.

Which other funds hold SOLV?

Other major institutional holders of SOLV include Independent Franchise Partners LLP, TRIAN FUND MANAGEMENT, L.P., DAVIS SELECTED ADVISERS, among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.